David Bechtel talks valuations, Barrow Funds' research process, factors driving the market, and a recent holding that he believes is a "gold standard company at a cheap price."
The thoughts and opinions expressed in the interview are those of the speakers as of June 9, 2016. The discussion of individual companies should not be considered a recommendation of such companies by the Fund’s investment adviser. The discussion is designed to provide a reader with an understanding of how the Fund’s investment adviser manages the Fund’s portfolio. There can be no assurance with regard to future market movements. Mutual fund investing involves risk. Principal loss is possible. The Fund’s investment objectives, risks, charges and expenses must be considered carefully before investing. The prospectus contains this and other important information about the Fund and may be obtained by calling 1-877- 767-6633. Read it carefully before investing. Distributed by Ultimus Fund Distributors, LLC. The Fund may invest in small- and mid-cap companies, which involves additional risks such as limited liquidity and greater volatility.
BALIX/BALAX – Top Ten Holdings as of March 31, 2016
Top Ten Holdings
|Holdings||% of Equity|
|Altria Group Inc.||1.46%|
|Philip Morris International Inc.||1.40%|
|Reynolds American Inc.||1.39%|
|USANA Health Sciences Inc.||1.27%|
|Johnson & Johnson||1.26%|
|Dr. Pepper Snapple Group Inc.||1.22%|
Fund holdings and sector allocations are subject to change at any time and should not be considered recommendations to buy or sell any security.